Form D · Pharmaceuticals
Victory Pharma Inc
San Diego, CA · CIK 0001459010
Offering snapshot reported Mar 23, 2009 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2009 | Initial | $9,999,997 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-128343
Source: Form D, filed Mar 23, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Barry | Director |
| Matthew Heck | Director, Executive |
| Herbert Hooper | Director |
| James Newman | Director, Executive |
| David Parker | Executive |
| David Snyder | Director |
| Daniel Stokely | Executive |
| Thomas Wiggans | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11682 El Camino Real Suite 250
San Diego, CA, 92130
San Diego, CA, 92130